Continuous-infusion vinblastine in refractory carcinoma of the cervix: A phase II trial
- 1 June 1985
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 21 (2) , 211-214
- https://doi.org/10.1016/0090-8258(85)90254-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Cervical carcinoma: A drug-responsive tumor—experience with combined cisplatin, vinblastine, and bleomycin therapyGynecologic Oncology, 1983
- Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinomaCancer, 1981
- MITOMYCIN-C, BLEOMYCIN, VINCRISTINE, AND CIS-PLATINUM IN THE TREATMENT OF ADVANCED, RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX1981
- Reporting results of cancer treatmentCancer, 1981
- VINBLASTINE GIVEN AS A CONTINUOUS 5-DAY INFUSION IN THE TREATMENT OF REFRACTORY ADVANCED BREAST-CANCER1980
- MITOMYCIN-C, VINCRISTINE, AND BLEOMYCIN THERAPY FOR ADVANCED CERVICAL-CANCER1978
- The integration of chemotherapy into combined modality treatment of solid tumors: VIII. Cervical cancerCancer Treatment Reviews, 1977
- PHARMACOKINETICS AND METABOLISM OF VINBLASTINE IN HUMANS1977
- Perspectives on research in gynecologic oncology.Treatment protocolsCancer, 1976
- Adriamycin and bleomycin, alone and in combination, in gynecologic cancersCancer, 1973